Terms: = Lung cancer AND CARS, P49589, 833, ENSG00000110619
278 results:
1. Development and validation of the hospice professional coping scale among Chinese nurses.
Zhang Y; Zheng L; He Y; Han M; Wang Y; Xv J; Qiu H; Yang L
BMC Health Serv Res; 2024 Apr; 24(1):491. PubMed ID: 38643136
[TBL] [Abstract] [Full Text] [Related]
2. Uniportal video-assisted thoracic surgery: segmentectomy versus lobectomy-early outcomes.
Sachs E; Jackson V; Al-Ameri M; Sartipy U
Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38547393
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB-IIIB lung squamous cell carcinoma.
Liu J; Zhu L; Tang M; Huang X; Gu C; He C; Lv X; Hu J
Sci Rep; 2024 Mar; 14(1):5523. PubMed ID: 38448498
[TBL] [Abstract] [Full Text] [Related]
4. Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC).
Wang X; He J; Li J; Wu C; Yue M; Niu S; Jia Y; Jia Z; Cai L; Liu Y
J Cancer Res Clin Oncol; 2024 Jan; 150(2):43. PubMed ID: 38280970
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy against lung cancer Is Augmented by Combining Aberrantly N-Glycosylated T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
Toyofuku T; Ishikawa T; Nojima S; Kumanogoh A
J Immunol; 2024 Mar; 212(5):917-927. PubMed ID: 38214607
[TBL] [Abstract] [Full Text] [Related]
6. Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1.
Kouro T; Higashijima N; Horaguchi S; Mano Y; Kasajima R; Xiang H; Fujimoto Y; Kishi H; Hamana H; Hoshino D; Himuro H; Matsuura R; Tsuji S; Imai K; Sasada T
Int J Cancer; 2024 May; 154(10):1828-1841. PubMed ID: 38212893
[TBL] [Abstract] [Full Text] [Related]
7. cancer incidence in Iran in 2016: A study based on the Iranian National cancer Registry.
Hadavandsiri F; Allahqoli L; Rahimi Y; Salehiniya H; Ghazanfari Savadkoohi E; Akbari ME
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1967. PubMed ID: 38148563
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Value of the Glasgow Prognostic Score in Non-Small Cell lung cancer Patients Receiving Immunotherapy: A Meta-Analysis.
Wang H; Yang R; Cheng C; Wang S; Liu D; Li W
Nutr Cancer; 2024; 76(2):187-195. PubMed ID: 38140926
[TBL] [Abstract] [Full Text] [Related]
9. [Analysis of disease burden of lung cancer attributable to chromium in Chinese population from 1990 to 2019].
Xiao SH; Wu PH; Han L; Liu X
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Nov; 41(11):825-831. PubMed ID: 38073209
[No Abstract] [Full Text] [Related]
10. Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score <50.
Pham TT; Gordon AS; Chen X; Debono D; Fisch MJ
Cancer Treat Res Commun; 2023; 37():100769. PubMed ID: 37839181
[TBL] [Abstract] [Full Text] [Related]
11. A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell lung cancer With Epidermal Growth Factor Receptor Mutation.
Zhao KX; Zhang YF; Zheng L; Pan YF; He ZH
Am J Clin Oncol; 2023 Dec; 46(12):551-558. PubMed ID: 37779240
[TBL] [Abstract] [Full Text] [Related]
12. Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Han X; Wang M; Zheng Y; Wang N; Wu Y; Ding C; Jia X; Yang R; Geng M; Chen Z; Zhang S; Zhang K; Li Y; Liu J; Gu J; Liao Y; Fan J; Shi H
Eur Radiol; 2024 Apr; 34(4):2716-2726. PubMed ID: 37736804
[TBL] [Abstract] [Full Text] [Related]
13. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
Kuan AS; Chiang CL; Wu HM; Yang HC; Chen CJ; Lin CJ; Guo WY; Pan DH; Chung WY; Lee CC
J Neurooncol; 2023 Sep; 164(3):729-739. PubMed ID: 37721662
[TBL] [Abstract] [Full Text] [Related]
14. Growing Deficit in New cancer Diagnoses 2 Years Into the COVID-19 Pandemic: A National Multicenter Study.
Englum BR; Sahoo S; Mayorga-Carlin M; Hayssen H; Siddiqui T; Turner DJ; Sorkin JD; Lal BK
Ann Surg Oncol; 2023 Dec; 30(13):8509-8518. PubMed ID: 37695458
[TBL] [Abstract] [Full Text] [Related]
15. Early life PM
Baranyi G; Williamson L; Feng Z; Tomlinson S; Vieno M; Dibben C
Environ Res; 2023 Dec; 238(Pt 1):117021. PubMed ID: 37659643
[TBL] [Abstract] [Full Text] [Related]
16. Assessing four-dimensional CT stress maps derived from patient-specific biomechanical models of the lung with pulmonary function test data in lung cancer patients.
Shiinoki T; Fujimoto K; Kawazoe Y; Yuasa Y; Kajima M; Manabe Y; Hirano T; Matsunaga K; Tanaka H
Br J Radiol; 2023 Sep; 96(1149):20221149. PubMed ID: 37393529
[TBL] [Abstract] [Full Text] [Related]
17. Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma.
Restle D; Dux J; Li X; Byun AJ; Choe JK; Li Y; Vaghjiani RG; Thomas C; Misawa K; Tan KS; Jones DR; Chintala NK; Adusumilli PS
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37349126
[TBL] [Abstract] [Full Text] [Related]
18. Risk profiles and a concise prediction model for lymph node metastasis in patients with lung adenocarcinoma.
Liang S; Huang YY; Liu X; Wu LL; Hu Y; Ma G
J Cardiothorac Surg; 2023 Jun; 18(1):195. PubMed ID: 37340322
[TBL] [Abstract] [Full Text] [Related]
19. Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast cancer: A Prospective Phase II Study.
Zhang JH; Li TT; Qin SR; Liu ZQ; Chen SY; Song YW; Tang Y; Jing H; Fang H; Zhao XR; Jin J; Liu YP; Tang Y; Qi SN; Li N; Chen B; Lu NN; Li YX; Wang SL
Technol Cancer Res Treat; 2023; 22():15330338231173773. PubMed ID: 37312511
[No Abstract] [Full Text] [Related]
20. Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice.
Pfeifer R; Al Rawashdeh W; Brauner J; Martinez-Osuna M; Lock D; Herbel C; Eckardt D; Assenmacher M; Bosio A; Hardt OT; Johnston ICD
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298141
[TBL] [Abstract] [Full Text] [Related]
[Next]
